Provided by Tiger Trade Technology Pte. Ltd.

Actinium Pharmaceuticals

1.02
+0.01000.99%
Volume:34.78K
Turnover:35.33K
Market Cap:32.00M
PE:2.87
High:1.03
Open:1.03
Low:1.01
Close:1.01
52wk High:1.78
52wk Low:0.7351
Shares:31.37M
Float Shares:31.25M
Volume Ratio:0.30
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3559
EPS(LYR):-1.0900
ROE:45.86%
ROA:11.58%
PB:1.06
PE(LYR):-0.94

Loading ...

Apr 26, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 03, 2024

Correspondence

Form CORRESP - Correspondence
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report